Gershon Capital
Overview
Gershon Capital is a private equity and venture capital firm based in New York, United States, focusing on early-stage life sciences companies in the US and Asia. The firm specializes in sectors such as biotechnology, medical devices, healthcare AI, wearable sensors, and health and wellness, targeting innovative technologies with strong commercial potential. Established in 2009, Gershon Capital operates through two main entities: Endeavor Venture Fund and Endeavor Venture Studio. Endeavor Venture Fund is an evergreen Swiss healthcare and life sciences venture fund that has invested in 94 companies, including notable names like Moderna. Endeavor Venture Studio, launched in 2022, provides up to $5 million in funding, strategic partnerships, and hands-on guidance to accelerate the growth and commercialization of emerging healthcare and life sciences products and services. The firm's investment strategy emphasizes a vertically integrated approach, leveraging a network of over 200 institutional, strategic, and high-net-worth investors across the US, Europe, and the Middle East. Gershon Capital's team of 32 professionals offers direct investment, equity and debt syndicated financing, and M&A advisory services, aiming to provide comprehensive financial and strategic solutions for emerging life science companies with innovative technologies and strong commercial potential.
Investment Focus
- Innovative technologies with strong commercial potential in life sciences sectors
- Early-stage companies seeking funding and strategic guidance
- Entrepreneurs and founders aiming to commercialize disruptive healthcare and life sciences products and services
Portfolio Companies
Reach Gershon Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Gershon Capital
What sectors does Gershon Capital invest in?
Gershon Capital invests in Digital Health, Medical Devices, Quantum Computing, Biotechnology, Health and Wellness and Precision Medicine, and is based in New York, United States. Gershon Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Gershon Capital invest at?
Gershon Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does Gershon Capital invest in?
Gershon Capital invests across United States, United Kingdom, China and Switzerland.
What companies has Gershon Capital invested in?
Gershon Capital's portfolio includes QuantHealth, Peloton Therapeutics, Moderna, PreciseDx, Remedial Health, neotiv, Rodin Therapeutics and Savia Health.
Last updated · Source: ConnectSafely investor database
